Medicaid Fee- for- Service Providers Dispense Brand Name Drug when Less Expensive than Generic Program Effective November 13, 2014, the following changes will be made to the Dispense Brand Name Drug when Less Expensive t - Canadian Aviation Regulation Advisory Council - Document - PDFSEARCH.IO

First Page	Meta Content
	Medicaid Fee- for- Service Providers Dispense Brand Name Drug when Less Expensive than Generic Program Effective November 13, 2014, the following changes will be made to the Dispense Brand Name Drug when Less Expensive t Add to Reading List Document Date: 2014-10-31 10:03:10 Open Document File Size: 190,21 KB Share Result on Facebook MedicalCondition HBV / / Product Wellbutrin / Combivir / Catapres-TTS / Pulmicort Respules / Alphagan P / Diovan HCT / Accolate / Hepsera / Wellbutrin XL / Lidoderm / Carbatrol / Trizivir / Name Drug / Aldara / Tegretol / Mepron / TOBI / Epivir / Exforge / Adderall XR / Trileptal / Bactroban / Diastat / Solaraze / Tobradex / Felbatol / Kadian / Pepcid / Niaspan / Myfortic / Soriatane / Gabitril / Depakote / Focalin XR / Carac / Symbyax / Ortho Evra / Baraclude / / SocialTag Combination drugs Bupropion Cathinones GlaxoSmithKline Medical prescription Adderall Famotidine Olanzapine/fluoxetine Canadian Aviation Regulation Advisory Council Pharmacology

Medicaid Fee- for- Service Providers Dispense Brand Name Drug when Less Expensive than Generic Program Effective November 13, 2014, the following changes will be made to the Dispense Brand Name Drug when Less Expensive tAdd to Reading List